Association of human papillomavirus type 16 long control region mutation and cervical cancer

Virology Journal

Volumn 10, Issue 1, 2013, Pages

  Pientong, Chamsai ^a   Wongwarissara, Parichat ^a   Ekalaksananan, Tipaya ^a   Swangphon, Piyawut ^a   Kleebkaow, Pilaiwan ^a   Kongyingyoes, Bunkerd ^a   Siriaunkgul, Sumalee ^b   Tungsinmunkong, Kobkul ^c   Suthipintawong, Cheepsumon ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Cervical cancer; HPV16; Long control region; Sub lineage Asian

Indexed keywords

PROTEIN E6; VIRUS DNA; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; CANCER RISK; CARCINOGENICITY; CLONING VECTOR; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA SEQUENCE; ENHANCER REGION; FEMALE; GENE ACTIVITY; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LONG CONTROL REGION; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; THAI (PEOPLE); UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN; GENE EXPRESSION PROFILING; GENETICS; MOLECULAR GENETICS; PAPILLOMAVIRUS INFECTION; REGULATORY SEQUENCE; THAILAND; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

DNA, VIRAL; FEMALE; GENE EXPRESSION PROFILING; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; THAILAND; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84872556377     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-30     Document Type: Article

References (25)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997, 71:2463-2472.
3. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Xu LY, Cheng AF: Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 2002, 186:696-700.
4. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, et al: The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993, 67:6413-6423.
5. Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM: Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol 2012, 86:6855-6861.
6. Stunkel W, Bernard HU: The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol 1999, 73:1918-1930.
7. Lace MJ, Isacson C, Anson JR, Lorincz AT, Wilczynski SP, Haugen TH, Turek LP: Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. J Virol 2009, 83:7457-7466.
8. Dong XP, Stubenrauch F, Beyer-Finkler E, Pfister H: Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994, 58:803-808.
9. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB: Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997, 89:796-802.
10. Veress G, Szarka K, Dong XP, Gergely L, Pfister H: Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 1999, 80(Pt 4):1035-1043.
11. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H: Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 2000, 81:1975-1981.
12. Chopjitt P, Ekalaksananan T, Pientong C, Kongyingyoes B, Kleebkaow P, Charoensri N: Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand. Int J Infect Dis 2009, 13:212-219.
13. Veress G, Murvai M, Szarka K, Juhasz A, Konya J, Gergely L: Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur J Cancer 2001, 37:1946-1952.
14. Giannoudis A, Herrington CS: Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001, 193:295-302.
15. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M: Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998, 352:1441-1442.
16. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU: Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 1991, 29:1765-1772.
17. Kim YB, Song YS, Jeon YT, Park JS, Um SJ, Kim JW, Park NH, Kang SB, Lee HP: Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women. Oncol Rep 2005, 14:459-464.
18. Park JS, Hwang ES, Lee CJ, Kim CJ, Rha JG, Kim SJ, Namkoong SE, Um SJ: Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol Oncol 1999, 74:23-29.
19. Kozuka T, Aoki Y, Nakagawa K, Ohtomo K, Yoshikawa H, Matsumoto K, Yoshiike K, Kanda T: Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn J Cancer Res 2000, 91:271-279.
20. Ishiji T, Lace MJ, Parkkinen S, Anderson RD, Haugen TH, Cripe TP, Xiao JH, Davidson I, Chambon P, Turek LP: Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J 1992, 11:2271-2281.
21. O'Connor M, Bernard HU: Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology 1995, 207:77-88.
22. O'Connor MJ, Tan SH, Tan CH, Bernard HU: YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 1996, 70:6529-6539.
23. Chen Z, Storthz KA, Shillitoe EJ: Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res 1997, 57:1614-1619.
24. Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, Pientong C, Ekalaksananan T, Karalak A, Kleebkaow P, Vinyuvat S, Triratanachat S, Khunamornpong S, Chongsuwanich T: Human papilloma virus prevalence, genotype distribution, and pattern of infection in thai women. Asian Pac J Cancer Prev 2011, 12:853-856.
25. de Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Kolkman-Uljee S, Fleuren GJ: Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 2004, 94:488-494.